Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Oncology | Hematology

Hematologic Cancer

Arizona

Peoria : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

California

Duarte : City of Hope

A Phase I/IIa Randomized, Observer-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Immunogenicity of the GSK Biologicals' Herpes Zoster Vaccine, gE/AS01B, in Comparison to gE Combined With 1/2 Dose AS01B Adjuvant (gE/AS01E) and to Saline (Placebo) When Administered as 2 Doses or 3 Doses to Autologous Hematopoietic Stem Cell Transplantation (HCT) Recipients.

Duarte : City of Hope

COG ALTE03N1: Key Adverse Events After Childhood Cancer

Duarte : City of Hope

Evaluation of Immune Responses Against Male-Specific Minor Histocompatibility Antigens (H-Y mHAg) in Recipients and Donors of Allogeneic Hematopoietic Stem Cell Transplantation

Duarte : City of Hope

Innovative Underserved Community-Based Cancer Risk Screening

Duarte : City of Hope

Long Term Follow-up Clinic for Survivors of Childhood Cancer

Duarte : City of Hope

NMDP 2002-0063: Research Database for Hematopoietic Stem Cell Transplantation and Marrow Toxic Injuries

Los Angeles : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Colorado

Denver : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Florida

Hialeah : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Illinois

Chicago : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Chicago : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Hines : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Missouri

Saint Louis : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

New Jersey

Newark : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

New York

East Syracuse : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

New York : Mount Sinai Medical Center

Phase I Multi-center Study of Intravenous BCX-1777 in Patients with Refractory Hematologic Malignancies

Rochester : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Rhode Island

Providence : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Texas

Houston : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Washington

Seattle : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Australia

South Granville : Merck Sharp & Dohme (Australia) Pty Ltd.

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals